Lavipharm Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	5.59	8.44	18.24	1.64
Short-Term Investments	-	-	-	0
Trading Asset Securities	-	0	0	-
Cash & Short-Term Investments	5.59	8.44	18.24	1.64
Cash Growth	-33.76%	-53.75%	1013.12%	-15.99%
Accounts Receivable	12.42	12.17	8.68	7.58
Other Receivables	3.72	2.85	5.2	5.33
Receivables	16.14	16.57	15.43	14.45
Inventory	20.49	16.21	10.44	9.24
Prepaid Expenses	0.86	1.38	-	-
Other Current Assets	1.92	3.06	1.49	0.64
Total Current Assets	45	45.65	45.6	25.96
Property, Plant & Equipment	21.36	19.54	17.06	17.46
Long-Term Investments	0	1.05	0.52	-
Other Intangible Assets	45.18	41.04	44.02	1.31
Long-Term Deferred Tax Assets	6.55	1.25	2.37	3.06
Long-Term Deferred Charges	4.5	3.5	2.18	1.83
Other Long-Term Assets	2.9	2.75	2.42	3.12
Total Assets	125.48	114.79	114.17	52.74
Accounts Payable	7.26	8.03	6.3	4.16
Accrued Expenses	2.81	3.06	6.65	4.46
Short-Term Debt	9.24	6.59	21.71	21.4
Current Portion of Long-Term Debt	1.43	1.51	-	-
Current Portion of Leases	0.91	0.68	0.52	0.66
Current Income Taxes Payable	0.25	0.24	0.51	0.1
Current Unearned Revenue	0.47	0.51	0.42	0.42
Other Current Liabilities	16.77	15.17	9.63	9.87
Total Current Liabilities	39.13	35.8	45.74	41.07
Long-Term Debt	12.17	12.7	3.96	4
Long-Term Leases	10.17	11	10.99	11.28
Pension & Post-Retirement Benefits	0.95	1.08	0.94	1.09
Other Long-Term Liabilities	10.1	11.44	12.23	5.25
Total Liabilities	72.52	72.02	73.86	62.68
Common Stock	50.61	50.36	50.36	51.08
Additional Paid-In Capital	7.17	7.41	7.41	84.42
Retained Earnings	-21.35	-30.24	-32.11	-159.96
Comprehensive Income & Other	16.56	15.21	14.62	14.48
Total Common Equity	52.98	42.74	40.28	-9.98
Minority Interest	-0.01	0.03	0.04	0.04
Shareholders' Equity	52.97	42.77	40.31	-9.94
Total Liabilities & Equity	125.48	114.79	114.17	52.74
Total Debt	33.92	32.48	37.18	37.33
Net Cash (Debt)	-28.34	-24.04	-18.93	-35.69
Net Cash Per Share	-0.17	-0.14	-0.88	-2.10
Filing Date Shares Outstanding	168.69	167.87	167.87	17.03
Total Common Shares Outstanding	168.69	167.87	167.87	17.03
Working Capital	5.88	9.85	-0.14	-15.11
Book Value Per Share	0.31	0.25	0.24	-0.59
Tangible Book Value	7.79	1.69	-3.74	-11.29
Tangible Book Value Per Share	0.05	0.01	-0.02	-0.66
Land	1.93	1.93	1.93	1.93
Buildings	2.72	1.74	1.53	1.49
Machinery	21.45	21.14	19.31	19.09

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.